216 related articles for article (PubMed ID: 17640598)
1. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
Nachbaur D; Schumacher P; Auberger J; Clausen J; Kircher B
Biol Blood Marrow Transplant; 2007 Aug; 13(8):942-7. PubMed ID: 17640598
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.
Min CK; Kim SY; Lee MJ; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Cho CS
Bone Marrow Transplant; 2006 Jul; 38(2):149-56. PubMed ID: 16751784
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease.
Kim DH; Lee NY; Lee MH; Sohn SK
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1408-16. PubMed ID: 19041064
[TBL] [Abstract][Full Text] [Related]
4. The interleukin-6 and vascular endothelial growth factor in hematopoietic stem cell transplantation.
Azarpira N; Dehghani M; Darai M
Saudi J Kidney Dis Transpl; 2012 May; 23(3):521-5. PubMed ID: 22569438
[TBL] [Abstract][Full Text] [Related]
5. Levels of insulin-like growth factor after stem cell transplantation.
Munker R; Salat C; Pihusch R; Diem H; Hiller E; Glass J; Kolb HJ; Yu H
Eur J Med Res; 2001 Apr; 6(4):181-4. PubMed ID: 11309231
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Norlin AC; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Bone Marrow Transplant; 2008 Feb; 41(3):267-73. PubMed ID: 17994123
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.
Pihusch V; Rank A; Steber R; Pihusch M; Pihusch R; Toth B; Hiller E; Kolb HJ
Transplantation; 2006 May; 81(10):1405-9. PubMed ID: 16732177
[TBL] [Abstract][Full Text] [Related]
8. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
9. Level of vascular endothelial growth factor predicts both relapse and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Moiseev IS; Lapin SV; Surkova EA; Lerner MY; Vavilov VN; Afanasyev BV
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1677-82. PubMed ID: 24035780
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
[TBL] [Abstract][Full Text] [Related]
11. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
12. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
14. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse.
Min CK; Kim SY; Eom KS; Kim YJ; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2006 Mar; 37(5):493-8. PubMed ID: 16435015
[TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
Nakamura R; Rodriguez R; Palmer J; Stein A; Naing A; Tsai N; Chang K; Slovak ML; Bhatia R; Spielberger R; Kogut N; Pullarkat V; Kirschbaum M; Forman SJ; O'Donnell MR
Bone Marrow Transplant; 2007 Nov; 40(9):843-50. PubMed ID: 17724447
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
17. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
18. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
[TBL] [Abstract][Full Text] [Related]
19. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]